"10.1371_journal.pone.0052985","plos one","2012-12-28T00:00:00Z","Ryan M Fryer; Akalushi Muthukumarana; Paul C Harrison; Suzanne Nodop Mazurek; Rong Rhonda Chen; Kyle E Harrington; Roger M Dinallo; Joshua C Horan; Lori Patnaude; Louise K Modis; Glenn A Reinhart","Department of Cardiometabolic Disease Research, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, United States of America; Department of Drug Discovery Support, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, United States of America; Department of Medicinal Chemistry, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, United States of America; Department of Immunology and Inflammation, Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, United States of America","Conceived and designed the experiments: RMF LKM GAR. Performed the experiments: AM PCH SNM RRC KEH RMD LP JCH. Analyzed the data: RMF AM PCH SNM RRC KEH RMD JCH LP LKM. Contributed reagents/materials/analysis tools: JCH. Wrote the paper: RMF LKM.","All authors were employed by Boehringer-Ingelheim Pharmaceuticals, Inc. at the time the research was performed. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials. The authors have declared that no other competing interests exist.","2012","12","Ryan M Fryer","RMF",11,TRUE,3,8,10,2,TRUE,TRUE,FALSE,0,NA,FALSE
